Patrick Cabri, M.D. [clinicaltrials_resource:326d3a7c00bd31764c0ee3c48aaa1d99]
clinicaltrials:NCT01020448A Study of the Potential Risk Factors Linked to the Development of Severe Forms of Endometriosis [clinicaltrials:NCT01351051]A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer [clinicaltrials:NCT01383863]A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [clinicaltrials:NCT01753297]
overall official [clinicaltrials_vocabulary:overall-official]
Patrick Cabri, M.D. [clinicaltrials_resource:326d3a7c00bd31764c0ee3c48aaa1d99]
Bio2RDF identifier
326d3a7c00bd31764c0ee3c48aaa1d99
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:326d3a7c00bd31764c0ee3c48aaa1d99
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
clinical.trials@ipsen.com
last name [clinicaltrials_vocabulary:last-name]
Patrick Cabri, M.D.
phone [clinicaltrials_vocabulary:phone]
clinical.trials@ipsen.com
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:326d3a7c00bd31764c0ee3c48aaa1d99
title
Patrick Cabri, M.D.
@en
type
label
Patrick Cabri, M.D. [clinicaltrials_resource:326d3a7c00bd31764c0ee3c48aaa1d99]
@en